Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Levin

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Proceedings. Biological Sciences|January 9, 2009
Oscillations in continuous culture populations of Streptococcus pneumoniae: population dynamics and the evolution of clonal suicideOmar E Cornejo, Daniel E Rozen, Robert M May, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2019
Antibiotic Killing of Diversely Generated Populations of Nonreplicating BacteriaIngrid C McCall, Nilang Shah, Adithi Govindan, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2009
Functional relationship between bacterial cell density and the efficacy of antibioticsKlas I Udekwu, Nicholas Parrish, Peter Ankomah, et al.
Plos One|June 27, 2015
Malthusian Parameters as Estimators of the Fitness of Microbes: A Cautionary Tale about the Low Side of High ThroughputJeniffer Concepción-Acevedo, Howard N Weiss, Waqas Nasir Chaudhry, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Modeling the role of bacteriophage in the control of cholera outbreaksMark A Jensen, Shah M Faruque, John J Mekalanos, et al.
Trends in Molecular Medicine|April 23, 2025
The future of phage therapy in the USABrandon A Berryhill, Teresa Gil-Gil, Andrew P Smith, et al.
NPJ Biofilms and Microbiomes|February 14, 2026
A theoretical exploration of protocols for treating prosthetic joint infections with combinations of antibiotics and bacteriophageBruce R Levin, Teresa Gil-Gil, Brandon A Berryhill, et al.
BMC Microbiology|November 28, 2002
Dynamics of success and failure in phage and antibiotic therapy in experimental infectionsJ J Bull, Bruce R Levin, Terry DeRouin, et al.
Plos Genetics|October 3, 2013
Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmidsWenyan Jiang, Inbal Maniv, Fawaz Arain, et al.
Lancet (London, England)|August 10, 2017
Evolution, human-microbe interactions, and life history plasticityGraham Rook, Fredrik Bäckhed, Bruce R Levin, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Proceedings. Biological Sciences|January 9, 2009
Oscillations in continuous culture populations of Streptococcus pneumoniae: population dynamics and the evolution of clonal suicideOmar E Cornejo, Daniel E Rozen, Robert M May, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2019
Antibiotic Killing of Diversely Generated Populations of Nonreplicating BacteriaIngrid C McCall, Nilang Shah, Adithi Govindan, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2009
Functional relationship between bacterial cell density and the efficacy of antibioticsKlas I Udekwu, Nicholas Parrish, Peter Ankomah, et al.
Plos One|June 27, 2015
Malthusian Parameters as Estimators of the Fitness of Microbes: A Cautionary Tale about the Low Side of High ThroughputJeniffer Concepción-Acevedo, Howard N Weiss, Waqas Nasir Chaudhry, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Modeling the role of bacteriophage in the control of cholera outbreaksMark A Jensen, Shah M Faruque, John J Mekalanos, et al.
Trends in Molecular Medicine|April 23, 2025
The future of phage therapy in the USABrandon A Berryhill, Teresa Gil-Gil, Andrew P Smith, et al.
NPJ Biofilms and Microbiomes|February 14, 2026
A theoretical exploration of protocols for treating prosthetic joint infections with combinations of antibiotics and bacteriophageBruce R Levin, Teresa Gil-Gil, Brandon A Berryhill, et al.
BMC Microbiology|November 28, 2002
Dynamics of success and failure in phage and antibiotic therapy in experimental infectionsJ J Bull, Bruce R Levin, Terry DeRouin, et al.
Plos Genetics|October 3, 2013
Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmidsWenyan Jiang, Inbal Maniv, Fawaz Arain, et al.
Lancet (London, England)|August 10, 2017
Evolution, human-microbe interactions, and life history plasticityGraham Rook, Fredrik Bäckhed, Bruce R Levin, et al.
Pageof 10